SPL 1.08% 9.2¢ starpharma holdings limited

Results from Perth nasal spray study? Did we get them?, page-5

  1. 79 Posts.
    lightbulb Created with Sketch. 26
    The trial was basically a safety study with a small number of people right?
    Perhaps the trial has become obsolete? Since the trial started, they got UK and EU approval and have now sold many thousands of units worldwide. Conducting a trial where a handful of people safely use it isn't exactly useful. But leaving us guessing as what happened to a trial that should be finished by now seems worse.

    I agree human efficacy trials could be good. However, if they went down that path they would need to do a LOT better with their marketing effort to recoup the trial expense.

    I mean what happened to our EU launch promised months ago?
    Are you telling me that opening a website known only to a handful of Aussie investors counts as a launch in the 27 EU countries?

    Not being given much insight into what company strategy is, it's easy for investors like ourselves to start thinking that they aren't really interested in putting any effort into selling Viraleze at all.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.